๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Peripheral neurotoxicity of taxol in patients previously treated with cisplatin

โœ Scribed by Ajay Anand; Mark Huberman; Guido Cavaletti; Giovanni Tredici


Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
186 KB
Volume
76
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Phase II trial of cisplatin (CPDD) in pr
โœ Joseph Brenner; Gordon B. Magill; Peter P. Sordillo; Edgar W. Cheng; Allan Yagod ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 249 KB ๐Ÿ‘ 1 views

Thirty-six previously treated adult patients with advanced soft tissue sarcomas received CPDD 120 mg/m2 with mannitol diuresis. There were only two (6%) partial responses and five (15%) minor responses in 34 evaluable patients. Toxicity included nausea and vomiting, myelosuppression, mild ototoxicit

Phase II study of paclitaxel in patients
โœ Shreyaskumar R. Patel; Nicholas E. Papadopoulos; Carl Plager; Kaye A. Linke; Ste ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 306 KB ๐Ÿ‘ 1 views

## BACKGROUND. Patients with osteosarcoma and its variants who did not respond to standard chemotherapy including doxorubicin. ifosfamide, cisplatin, and high dose methotrexate were treated with paclitaxel so that its therapeutic activity in these patients could be determined. ## METHODS. We co

Distribution of platinum in patients tre
โœ K. Heydorn; B. Rietz; A. Krarup-Hansen ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 41 KB ๐Ÿ‘ 1 views

Cisplatin is used in a successful treatment of testicular cancer and some related conditions, but several toxic effects have been observed. Knowledge about the distribution of platinum in the human body after treatment with massive doses of cisplatin might provide clues to the origin of side effects

A multicenter, Phase II trial of weekly
โœ Mace L. Rothenberg; John V. Cox; Russell F. DeVore; John D. Hainsworth; Richard ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 110 KB ๐Ÿ‘ 1 views

## Background: This multicenter, phase ii trial was performed to evaluate the antitumor activity and toxicity of irinotecan (cpt-11) in patients with metastatic colorectal carcinoma that had recurred or progressed after 5-fluorouracil (5-fu)-based chemotherapy. ## Methods: Cpt-11 was given as a 9